The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma

European Journal of Cancer

Volumn 46, Issue 9, 2010, Pages 1640-1649

  Zhi, Feng ^a   Chen, Xi ^b   Wang, Suinuan ^a   Xia, Xiwei ^a   Shi, Yimin ^a   Guan, Wei ^a   Shao, Naiyuan ^a   Qu, Hongtao ^a   Yang, Changchun ^a   Zhang, Yi ^a   Wang, Qiang ^a   Wang, Rong ^a   Zen, Ke ^b   Zhang, Chen Yu ^b   Zhang, Junfeng ^b   Yang, Yilin ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Astrocytoma; microRNA; Survival

Indexed keywords

MICRORNA; MIRN106 MICRORNA, HUMAN; MIRN181 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN SURGERY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; BRAIN TUMOR; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PROTEIN MICROARRAY;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROTEIN ARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; KAPLAN-MEIER ESTIMATE;

EID: 77952583615     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.02.003     Document Type: Article

References (30)

1. Walker D.G., and Kaye A.H. Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: a review. Austral Radiol 45 (2001) 472-482
2. Mathieu D., and Fortin D. The role of chemotherapy in the treatment of malignant astrocytomas. Can J Neurol Sci 33 (2006) 127-140
3. Okamoto Y., Di Patre P.L., Burkhard C., et al. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 108 (2004) 49-56
4. Chosdol K., Misra A., Puri S., et al. Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors. BMC Cancer 9 (2009) 5
5. Oji Y., Suzuki T., Nakano Y., et al. Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors. Cancer Sci 95 (2004) 822-827
6. Shiraishi S., Tada K., Nakamura H., et al. Influence of p53 mutations on prognosis of patients with glioblastoma. Cancer 95 (2002) 249-257
7. Esquela-Kerscher A., and Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6 (2006) 259-269
8. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 6 (2006) 857-866
9. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
10. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103 (2006) 2257-2261
11. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
12. Iorio M.V., Ferracin M., Liu C.G., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65 (2005) 7065-7070
13. Yanaihara N., Caplen N., Bowman E., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198
14. Calin G.A., Ferracin M., Cimmino A., et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. New Engl J Med 353 (2005) 1793-1801
15. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
16. Chen C., Ridzon D.A., Broomer A.J., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33 (2005) e179
17. Tang F., Hajkova P., Barton S.C., Lao K., and Surani M.A. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 34 (2006) e9
18. Hebert S.S., Horre K., Nicolai L., et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 105 (2008) 6415-6420
19. Ben-Ami O., Pencovich N., Lotem J., Levanon D., and Groner Y. A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. Proc Natl Acad Sci USA 106 (2009) 238-243
20. Peltier H.J., and Latham G.J. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14 (2008) 844-852
21. Conti A., Aguennouz M., La Torre D., et al. MiR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J Neurooncol 93 (2009) 325-332
22. Silber J., Lim D.A., Petritsch C., et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6 (2008) 14
23. Calin G.A., Sevignani C., Dumitru C.D., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101 (2004) 2999-3004
24. Sempere L.F., Freemantle S., Pitha-Rowe I., et al. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5 (2004) R13
25. Beuvink I., Kolb F.A., Budach W., et al. A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs. Nucleic Acids Res 35 (2007) e52
26. Liang Y., Ridzon D., Wong L., and Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8 (2007) 166
27. Meng F., Henson R., Wehbe-Janek H., et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 (2007) 647-658
28. Chen Y., Liu W., Chao T., et al. MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett 272 (2008) 197-205
29. Shi L., Cheng Z., Zhang J., et al. hsa-mir-181a and hsa-mir-181b Function as tumor suppressors in human glioma cells. Brain Res 1236 (2008) 185-193
30. Diaz R., Silva J., Garcia J.M., et al. Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer 47 (2008) 794-802